Literature DB >> 2560176

Neurotensin elevates cytosolic calcium in small cell lung cancer cells.

J Staley1, G Fiskum, T P Davis, T W Moody.   

Abstract

The ability of neurotensin (NT) to elevate cytosolic Ca2+ in small cell lung cancer (SCLC) cells was investigated using the fluorescent Ca2+ indicator Fura 2-AM. Using SCLC cell line NCI-H345, NT elevated cytosolic Ca2+ levels in a concentration-dependent manner. Using a 10 nM dose, NT and C-terminal fragments such as NT(8-13) but not N-terminal fragments such as NT(1-8) elevated the cytosolic Ca2+ levels. Because EGTA (5 mM) did not affect the NT response, NT may cause release of Ca2+ from intracellular stores. These data indicate that SCLC NT receptors may use Ca2+ as a second messenger.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2560176     DOI: 10.1016/0196-9781(89)90015-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

Review 1.  New perspectives in lung cancer. 2. Growth factors and lung cancer.

Authors:  P J Woll
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

2.  Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3.

Authors:  Terry W Moody; Irene Ramos-Alvarez; Robert T Jensen
Journal:  Peptides       Date:  2022-08-03       Impact factor: 3.867

3.  Expression of neurotensin messenger RNA in a human carcinoid tumor.

Authors:  B M Evers; J Ishizuka; C M Townsend; S Rajaraman; J C Thompson
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

4.  Neurotensin expression and release in human colon cancers.

Authors:  B M Evers; J Ishizuka; D H Chung; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969

5.  Neurotensin regulates growth of human pancreatic cancer.

Authors:  J Ishizuka; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

6.  SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.

Authors:  Terry W Moody; Daniel C Chan; Samuel A Mantey; Paola Moreno; Robert T Jensen
Journal:  Life Sci       Date:  2014-02-02       Impact factor: 5.037

Review 7.  Neuropeptide growth factors and cancer.

Authors:  P J Woll
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

8.  Neurotensin receptors regulate transactivation of the EGFR and HER2 in a reactive oxygen species-dependent manner.

Authors:  Terry W Moody; Lingaku Lee; Irene Ramos-Alvarez; Robert T Jensen
Journal:  Eur J Pharmacol       Date:  2019-10-12       Impact factor: 4.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.